竞彩足球总进球过关|中国在世界杯总进球数|

生物新药发现

生物工艺

检测

定制化蛋白药物生产

商业化生产

制剂产品灌装生产

抗体?#21058;?#33647;物

技术与平台

Corporate Profile ?????? 中文

WUXI BIOLOGICS (CAYMAN) INC. (“WUXI BIOLOGICS” or the “Company”), is a global leading biologics services provider that offers comprehensive, integrated and highly customizable services through its teams of scientists, proprietary technology platform and know-how, state-of-the-art laboratories, and cGMP-compliant manufacturing facilities to pharmaceutical and biotechnology companies.

The company is the a leading global open-access biologics technology platform in the world offering end-to-end solutions, empowering anyone to discover, develop and manufacture biologics from concept to commercial manufacturing. Its business model is built upon a “follow the molecule” strategy, whereby customers’ demand for the company’s services increases as their biologics advance through development and ultimately to commercialization, which allows its revenue from each integrated project to grow as the project advances.

Headquartered in Wuxi, Jiangsu, China with three operation sites located in Wuxi, Shanghai and Suzhou, respectively, WuXi Biologics is the dominant leader in China’s biologics services market with 63.5% market share in terms of revenue in 2017 and also held leading market positions globally. To date, the company has worked with 13 out of the 20 largest pharmaceuticals companies in the world, including renowned industry players such as AstraZeneca and Genentech.

WuXi Biologics: Transforming and accelerating pharmaceutical discovery, development and manufacturing in the fast growing field of biologics to benefit patients worldwide.

BACK
竞彩足球总进球过关
足球赛投注网 海南飞鱼开奖直播 湖南幸运赛车历史开奖结果 黑龙江11选5万能码 高手靠3d赚钱 山东群英会中奖有效期 天易棋牌 斗地主 七星彩17131期号码预测 宁夏11选5开奖走势图 长沙湖南省福彩中心地址